Direkt zum Inhalt
Merck

In vitro model to study the effects of matrix stiffening on Ca

The Journal of physiology (2017-05-10)
Elza D van Deel, Aref Najafi, Dulce Fontoura, Erik Valent, Max Goebel, Kim Kardux, Inês Falcão-Pires, Jolanda van der Velden
ZUSAMMENFASSUNG

This paper describes a novel model that allows exploration of matrix-induced cardiomyocyte adaptations independent of the passive effect of matrix rigidity on cardiomyocyte function. Detachment of adult cardiomyocytes from the matrix enables the study of matrix effects on cell shortening, Ca Extracellular matrix (ECM) stiffening is a key element of cardiac disease. Increased rigidity of the ECM passively inhibits cardiac contraction, but if and how matrix stiffening also actively alters cardiomyocyte contractility is incompletely understood. In vitro models designed to study cardiomyocyte-matrix interaction lack the possibility to separate passive inhibition by a stiff matrix from active matrix-induced alterations of cardiomyocyte properties. Here we introduce a novel experimental model that allows exploration of cardiomyocyte functional alterations in response to matrix stiffening. Adult rat cardiomyocytes were cultured for 24 h on matrices of tuneable stiffness representing the healthy and the diseased heart and detached from their matrix before functional measurements. We demonstrate that matrix stiffening, independent of passive inhibition, reduces cell shortening and Ca

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
(3-Aminopropyl)trimethoxysilan, 97%